Lataa...
Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
Just over a decade ago, gastrointestinal tumours were a poorly understood mesenchymal neoplasm unsuccessfully treated with chemotherapy. Cytotoxic therapy for advanced disease yielded response rates of 10% and median survival of just 18 months. However, the discovery of KIT and platelet derived grow...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Libertas Academica
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3235999/ https://ncbi.nlm.nih.gov/pubmed/22174597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S4259 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|